الصفحة الرئيسية>>Signaling Pathways>> DNA Damage/DNA Repair>> Eukaryotic Initiation Factor (eIF)>>Didesmethylrocaglamide

Didesmethylrocaglamide

رقم الكتالوجGC39808

ديديسميثيلروكاجلاميد Didesmethylrocaglamide ، أحد مشتقات Rocaglamide ، هو مثبط قوي لعامل بدء حقيقيات النوى 4A (eIF4A)Didesmethylrocaglamide له نشاط مثبط قوي للنمو مع IC 50 من 5 نانومتريقوم Didesmethylrocaglamide بقمع العديد من مسارات الإشارات المعززة للنمو ويحث على موت الخلايا المبرمج في الخلايا السرطانيةنشاط انتيتومور

Products are for research use only. Not for human use. We do not sell to patients.

Didesmethylrocaglamide التركيب الكيميائي

Cas No.: 177262-30-5

الحجم السعر المخزون الكميّة
5mg
603٫00
متوفر
10mg
1066٫00
متوفر
25mg
1993٫00
متوفر
50mg
3476٫00
متوفر
100mg
5516٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Didesmethylrocaglamide, a derivative of Rocaglamide, is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. Didesmethylrocaglamide has potent growth-inhibitory activity with an IC50 of 5 nM. Didesmethylrocaglamide suppresses multiple growth-promoting signaling pathways and induces apoptosis in tumor cells. Antitumor activity[1].

[1]. Long-Sheng Chang, et al. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas. Mol Cancer Ther. 2020 Mar;19(3):731-741.

مراجعات

Review for Didesmethylrocaglamide

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Didesmethylrocaglamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.